Preventing ovarian hyperstimulation syndrome by inhibiting the effects of vascular endothelial growth factor

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 48, Issue 4, 2003, Pages 243-246

  McElhinney, Bernie ^a   Ardill, Joy ^b   Caldwell, Carolyn ^b   McClure, Neil ^b  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b NONE

Author keywords

Endothelial growth factors; Infertility, female; Ovarian hyperstimulation syndrome; Reproduction techniques

Indexed keywords

EVANS BLUE; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAPILLARY PERMEABILITY; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; FEMALE; FEMALE INFERTILITY; HEMOCONCENTRATION; HORMONAL REGULATION; NONHUMAN; OVARY FOLLICLE DEVELOPMENT; OVARY HYPERSTIMULATION; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; TUMOR GROWTH; VASCULAR ENDOTHELIUM;

ANALYSIS OF VARIANCE; ANIMALS; DISEASE MODELS, ANIMAL; ENDOTHELIAL GROWTH FACTORS; EVANS BLUE; FEMALE; FOLLICLE STIMULATING HORMONE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; OVARIAN HYPERSTIMULATION SYNDROME; PROBABILITY; PROTEIN-TYROSINE KINASES; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0037399374     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Aiello LP, Pierce EA, Foley ED, et al: Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci USA 1995;92:10457-10461
2. Asano M, Yukita A, Matsumoto T, et al: Inhibition of tumor growth and metastasis by an immunoneutralizing monoclonal antibody to human vascular endothelial growth factor/vascular permeability factor 121. Cancer Res 1995;55:5296-5301
3. Clauss M, Weich HA, Breier G, et al: The vascular endothelial growth factor receptor Flt-1 mediates biological activities: Implications for a functional role of placenta growth facator in monocyte activation and chemotaxis. J Biol Chem 1996;271:17629-17634
4. Dvorak HF, Brown LF, Detmar M, et al: Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995;146:1029-1039
5. Ferrara N, Chen H, Davis-Smyth T, et al: Vascular endothelial growth factor is essential for corpus luteum angiogenesis. Nature Med 1998;4:336-340
6. Goldman CK, Kendall RL, Cabrera G, et al: Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate. Proc Natl Acad Sci USA 1998;95:8795-8800
7. Kamat B, Brown L, Manseau E, et al: Expression of vascular permeability factor/vascular endothelial growth factor by human granulosa and theca lutein cells. Am J Pathol 1995;146:157-165
8. Kendall R, Thomas K: Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci USA 1993;90:10705-10709
9. Kim KJ, Li B, Winer J, et al: Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 1993;362:841-844
10. McClure N, Healy DL: Ovarian hyperstimulation syndrome. Lancet 1991;338:1111-1112
11. McClure N, Healy DL, Rogers PAW, et al: Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome. Lancet 199;344:235-236
12. Roeckl W, Hecht D, Sztajer H, et al: Differential binding characteristics and cellular inhibition by soluble VEGF receptors 1 and 2. Exp Cell Res 1998;241:161-170
13. Shibuya M, Yamaguchi S, Yamane A, et al: Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt-1) closely related to the fms family. Oncogene 1990;5:519-524
14. Ujioka T, Matsuura K, Kawano T, et al: Role of progesterone in capillary permeability in hyperstimulated rats. Hum Reprod 1997;12:1629-1634